Peter Rossing

Brigham and Women's Hospital US

0000-0002-1531-4294

1,360

Publications

77,081

Citations

121

H-Index

606

i10-Index

14.3

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

1,338 total

Dapagliflozin in Patients with Chronic Kidney Disease PDF

Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter, Glenn M. Chertow, Tom Greene et al. - New England Journal of Medicine, 2020

Cited by 4,983 OpenAlex

Decision letter for "Effects of 6weeks treatment with dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a randomized placebo-controlled exploratory study"

P. Rossing - Unknown Venue, 2020

Cited by 1 Semantic Scholar

[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study].

M. Gall, P. Rossing, P. Skøtt, E. Hommel, E. Mathiesen - Ugeskrift for læger, 1993

Cited by 0 Semantic Scholar

Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.

Mari-Anne Gall, P. Rossing, P. Skøtt, Eva Rommel, E. Mathiesen - American Journal of Hypertension, 1992

Cited by 17 Semantic Scholar

Research Topics

Diabetes Treatment and Management (413) Chronic Kidney Disease and Diabetes (297) Diabetes Management and Research (217) Blood Pressure and Hypertension Studies (216) Hormonal Regulation and Hypertension (186)

Affiliations

University College Dublin

IE 2018 - 2018

Statens Serum Institut

DK 2007 - 2007

Uppsala University

SE 2019 - 2019

University of Copenhagen

DK 2025 - 1991

SIB Swiss Institute of Bioinformatics

CH 2019 - 2019

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Peter Rossing

Publication & Citation Trends

Publications

Dapagliflozin in Patients with Chronic Kidney Disease PDF

Decision letter for "Effects of 6weeks treatment with dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: a randomized placebo-controlled exploratory study"

[The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study].

Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back